Can-fite Biopharma
CANF

Can-fite Biopharma (CANF) analyst forecast and price target

Analyst forecast

Buy

Consensus of 1 analyst rating

Buy
1
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$8.00 from $5.00Jul 2, 2026
D. Boral CapitalUpgradedHold → Buy$7.00May 13, 2026
HC Wainwright & Co.MaintainedBuy$5.00 from $2.50May 12, 2026
D. Boral CapitalMaintainedBuy$4.00 from $11.00Dec 17, 2025
D. Boral CapitalMaintainedBuy$11.00Nov 18, 2025
HC Wainwright & Co.Initiated CoverageBuy$2.50Nov 4, 2025
D. Boral CapitalMaintainedBuy$11.00Sep 16, 2025
D. Boral CapitalMaintainedBuy$11.00Sep 2, 2025
D. Boral CapitalMaintainedBuy$10.00Jul 29, 2025
D. Boral CapitalMaintainedBuy$10.00Apr 15, 2025
D. Boral CapitalMaintainedBuy$10.00Mar 21, 2025
D. Boral CapitalMaintainedBuy$10.00Mar 20, 2025
D. Boral CapitalMaintainedBuy$10.00Mar 18, 2025
D. Boral CapitalMaintainedBuy$10.00Mar 3, 2025
D. Boral CapitalMaintainedBuy$10.00Feb 18, 2025
D. Boral CapitalMaintainedBuy$10.00Dec 31, 2024
D. Boral CapitalMaintainedBuy$10.00Dec 5, 2024
HC Wainwright & Co.MaintainedBuy$18.00Nov 12, 2024
EF HuttonMaintainedBuy$10.00Oct 10, 2024
EF HuttonMaintainedBuy$10.00Sep 24, 2024

Frequently asked questions

  • Is CANF a buy, sell, or hold?

    Analysts covering Can-fite Biopharma currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on CANF?

    On Jul 2, 2026, HC Wainwright & Co. maintained Can-fite Biopharma at Buy with a price target of $8.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.